ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma

Chen, Zetao; Chen, Yihong; Li, Yan; Lian, Weidong; Zheng, Kehong; Zhang, Yuxuan; Zhang, Yujie; Lin, Chuang; Liu, Chaoqun; Sun, Fei; Sun, Xinlin; Wang, Jihui*; Zhao, Liang*; Ke, Yiquan*南方医科大学
Cell Death & Disease2021-6-15DOI: 10.1038/s41419-021-03882-7
25被引9阅读
引用收藏
分享

摘要

Glioma is one of the most lethal cancers with highly vascularized networks and growing evidences have identified glioma stem cells (GSCs) to account for excessive angiogenesis in glioma. Aberrant expression of paired-related homeobox1 (Prrx1) has been functionally associated with cancer stem cells including GSCs. In this study, Prrx1 was found to be markedly upregulated in glioma specimens and elevated Prrx1 expression was inversely correlated with prognosis of glioma patients. Prrx1 potentiated stemness acquisition in non-stem tumor cells (NSTCs) and stemness maintenance in GSCs, accompanied with increased expression of stemness markers such as SOX2. Prrx1 also promoted glioma angiogenesis by upregulating proangiogenic factors such as VEGF. Consistently, silencing Prrx1 markedly inhibited glioma proliferation, stemness, and angiogenesis in vivo. Using a combination of subcellular proteomics and in vitro analyses, we revealed that Prrx1 directly bound to the promoter regions of TGF-beta 1 gene, upregulated TGF-beta 1 expression, and ultimately activated the TGF-beta /smad pathway. Silencing TGF-beta 1 mitigated the malignant behaviors induced by Prrx1. Activation of this pathway cooperates with Prrx1 to upregulate the expression of stemness-related genes and proangiogenic factors. In summary, our findings revealed that Prrx1/TGF-beta /smad signal axis exerted a critical role in glioma stemness and angiogeneis. Disrupting the function of this signal axis might represent a new therapeutic strategy in glioma patients.

学科与关键词

关键词
POOR-PROGNOSISHOMEOBOX 1CELLSGLIOBLASTOMATUMORIGENICITYPROLIFERATIONCOLONIZATIONMETASTASISTHERAPYINDUCER
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cell Death & Disease
发表日期
2021-06-15
卷期
第 12 卷, 第 6 期
页码
615
DOI
10.1038/s41419-021-03882-7
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072762, 81772651, 81772652, 81802481]; Natural Science Foundation of Guangdong Province [2018A030310423]; President Foundation of ZhuJiang Hospital, Southern Medical University [yzjj2018rc04]; China Postdoctoral Science Foundation [2020M672737]

作者

  • C

    Chen, Zetao (第一作者)

    southern med univ

  • C

    Chen, Yihong

    southern med univ

查看全部 14 位作者收起作者
  • L

    Li, Yan

    southern med univ

  • L

    Lian, Weidong

    southern med univ

  • Z

    Zheng, Kehong

    southern med univ

  • Z

    Zhang, Yuxuan

    southern med univ

  • Z

    Zhang, Yujie

    southern med univ

  • L

    Lin, Chuang

    southern med univ

  • L

    Liu, Chaoqun

    southern med univ

  • S

    Sun, Fei

    southern med univ

  • S

    Sun, Xinlin

    southern med univ

  • W

    Wang, Jihui (通讯)

    southern med univ

  • Z

    Zhao, Liang (通讯)

    southern med univ

  • K

    Ke, Yiquan (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417